323 related articles for article (PubMed ID: 27609404)
1. Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.
Borza DB
Matrix Biol; 2017 Jan; 57-58():299-310. PubMed ID: 27609404
[TBL] [Abstract][Full Text] [Related]
2. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK
Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046
[TBL] [Abstract][Full Text] [Related]
3. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane.
Goldberg S; Harvey SJ; Cunningham J; Tryggvason K; Miner JH
Nephrol Dial Transplant; 2009 Jul; 24(7):2044-51. PubMed ID: 19144998
[TBL] [Abstract][Full Text] [Related]
4. The glomerular basement membrane as a barrier to albumin.
Suh JH; Miner JH
Nat Rev Nephrol; 2013 Aug; 9(8):470-7. PubMed ID: 23774818
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural localization of the three major basement membrane components--type IV collagen, heparan sulfate proteoglycan and laminin--in human membranous glomerulonephritis.
Haramoto T; Makino H; Ikeda S; Wieslander J; Ota Z
Am J Nephrol; 1994; 14(1):30-6. PubMed ID: 8017478
[TBL] [Abstract][Full Text] [Related]
6. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
7. The glomerular basement membrane.
Miner JH
Exp Cell Res; 2012 May; 318(9):973-8. PubMed ID: 22410250
[TBL] [Abstract][Full Text] [Related]
8. Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane.
Miner JH
Organogenesis; 2011; 7(2):75-82. PubMed ID: 21519194
[TBL] [Abstract][Full Text] [Related]
9. Inherited diseases of the glomerular basement membrane.
Gubler MC
Nat Clin Pract Nephrol; 2008 Jan; 4(1):24-37. PubMed ID: 18094725
[TBL] [Abstract][Full Text] [Related]
10. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
11. The role of the alternative pathway of complement activation in glomerular diseases.
Łukawska E; Polcyn-Adamczak M; Niemir ZI
Clin Exp Med; 2018 Aug; 18(3):297-318. PubMed ID: 29450785
[TBL] [Abstract][Full Text] [Related]
12. Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice.
Krishnan MR; Wang C; Marion TN
Kidney Int; 2012 Jul; 82(2):184-92. PubMed ID: 22297676
[TBL] [Abstract][Full Text] [Related]
13. Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis.
Raats CJ; Luca ME; Bakker MA; Van Der Wal A; Heeringa P; Van Goor H; Van Den Born J; De Heer E; Berden JH
J Am Soc Nephrol; 1999 Aug; 10(8):1689-99. PubMed ID: 10446936
[TBL] [Abstract][Full Text] [Related]
14. Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride.
Aten J; Veninga A; Bruijn JA; Prins FA; de Heer E; Weening JJ
Clin Immunol Immunopathol; 1992 Apr; 63(1):89-102. PubMed ID: 1591888
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
Miettinen A; Stow JL; Mentone S; Farquhar MG
J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
[TBL] [Abstract][Full Text] [Related]
16. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity.
Harvey SJ; Jarad G; Cunningham J; Rops AL; van der Vlag J; Berden JH; Moeller MJ; Holzman LB; Burgess RW; Miner JH
Am J Pathol; 2007 Jul; 171(1):139-52. PubMed ID: 17591961
[TBL] [Abstract][Full Text] [Related]
17. Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy.
Floege J; Johnson RJ; Gordon K; Yoshimura A; Campbell C; Iruela-Arispe L; Alpers CE; Couser WG
Kidney Int; 1992 Sep; 42(3):573-85. PubMed ID: 1383596
[TBL] [Abstract][Full Text] [Related]
18. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
19. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
Front Immunol; 2021; 12():676662. PubMed ID: 34489931
[TBL] [Abstract][Full Text] [Related]
20. Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy.
Borza DB
Front Immunol; 2016; 7():157. PubMed ID: 27199983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
